in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—11 June 2013
7:04 AM MDT | June 11, 2013 | Deepti Ramesh
Johnson Matthey's fine chemicals division reports higher profits Johnson Matthey's fine chemicals division posted a 2% hike in underlying operating profit for the fiscal year ended 31 March, to £71.1 million ($110 million), on sales down 2%, to £286 million. "After two years of strong growth, the performance of the fine chemicals division was impacted by increased competition in the UK regulated market in 2012–13," Johnson Matthey says. The division’s research chemicals business, which operates globally under the Alfa Aesar brand...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee